Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer
- 1 December 1996
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (14), 2528-2533
- https://doi.org/10.1016/s0959-8049(96)00398-x
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Recent advances in matrix metalloproteinase inhibitor researchDrug Discovery Today, 1996
- Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitorBiochemistry, 1995
- Low Molecular Weight Inhibitors in Corneal UlcerationaAnnals of the New York Academy of Sciences, 1994
- Inhibition of angiogenesis by tissue inhibitor of metalloproteinaseJournal of Cellular Physiology, 1994
- Association Between Expression of Activated 72-Kilodalton Gelatinase and Tumor Spread in Non-Small-Cell Lung CarcinomaJNCI Journal of the National Cancer Institute, 1993
- Mechanisms of tissue destruction and cellular activation in rheumatoid arthritisCurrent Opinion in Rheumatology, 1992
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990
- Inhibition of Collagenolytic Activity and Metastasis of Tumor Cells by a Recombinant Human Tissue Inhibitor of MetalloproteinasesJNCI Journal of the National Cancer Institute, 1990
- Collagenase in Rheumatoid ArthritisAnnals of the New York Academy of Sciences, 1985
- Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activityNature, 1985